Search details
1.
Hepcidin is suppressed by erythropoiesis in hemoglobin E ß-thalassemia and ß-thalassemia trait.
Blood
; 125(5): 873-80, 2015 Jan 29.
Article
in English
| MEDLINE | ID: mdl-25519750
2.
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.
Haematologica
; 102(10): 1640-1649, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28642302
3.
Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial.
J Pediatr
; 170: 45-53.e1-4, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26746121
4.
Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.
Haematologica
; 101(1): 38-45, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26385212
5.
Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.
N Engl J Med
; 367(26): 2495-504, 2012 Dec 27.
Article
in English
| MEDLINE | ID: mdl-23268664
6.
Childhood outcomes after hypothermia for neonatal encephalopathy.
N Engl J Med
; 366(22): 2085-92, 2012 May 31.
Article
in English
| MEDLINE | ID: mdl-22646631
7.
A novel method for non-transferrin-bound iron quantification by chelatable fluorescent beads based on flow cytometry.
Biochem J
; 463(3): 351-62, 2014 Nov 01.
Article
in English
| MEDLINE | ID: mdl-25093426
8.
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.
Br J Haematol
; 167(5): 692-6, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25209728
9.
Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).
J Pediatr
; 165(2): 240-249.e4, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24725582
10.
Effect of an enhanced medical home on serious illness and cost of care among high-risk children with chronic illness: a randomized clinical trial.
JAMA
; 312(24): 2640-8, 2014.
Article
in English
| MEDLINE | ID: mdl-25536255
11.
Increased leucocyte apoptosis in transfused ß-thalassaemia patients.
Br J Haematol
; 160(3): 399-403, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23216540
12.
Combined chelation therapy with deferasirox and deferoxamine in thalassemia.
Blood Cells Mol Dis
; 50(2): 99-104, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23151373
13.
Neurodevelopmental outcome of extremely low birth weight infants with Candida infection.
J Pediatr
; 163(4): 961-7.e3, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23726546
14.
Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone.
J Cardiovasc Magn Reson
; 15: 38, 2013 May 20.
Article
in English
| MEDLINE | ID: mdl-23688265
15.
Prevalence of oral trauma in Para-Pan American Games athletes.
Dent Traumatol
; 29(4): 280-4, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-22882839
16.
Electroencephalographic (EEG) Biomarkers in Genetic Neurodevelopmental Disorders.
J Child Neurol
; 38(6-7): 466-477, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37264615
17.
Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive function.
Neurogenetics
; 13(4): 333-9, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22890812
18.
Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes.
J Pediatr
; 161(2): 222-8.e3, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22421261
19.
Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response.
Haematologica
; 97(6): 835-41, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22180427
20.
Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variants.
NPJ Genom Med
; 7(1): 13, 2022 Feb 21.
Article
in English
| MEDLINE | ID: mdl-35190550